Public Law 116–335: To direct the Director of the National Science Foundation to support research on opioid addiction, and for other purposes. Public Law335 Public Law 116–335134 Stat. 5117 2021-01-13 2021-01-13 United States Government Publishing OfficeNational Archives and Records AdministrationOffice of the Federal Registertext/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. GPO Locator to USLM Converter 4.15.31;Stage2.202507022026-01-02 116public PUBLIC LAW 116–335—JAN. 13, 2021 134 STAT. 5117 Public Law116–335 116th Congress
An Act To direct the Director of the National Science Foundation to support research on opioid addiction, and for other purposes.

Jan. 13, 2021

[H.R. 3153]

   Be it enacted by the Senate and House of Representa­tives of the United States of America in Congress assembled,

Expanding Findings for Federal Opioid Research and Treatment Act.

42 USC 1861 note.
SECTION 1. SHORT TITLE; FINDINGS.(a) Short Title.—This Act may be cited as the “Expanding Findings for Federal Opioid Research and Treatment Act” or the “EFFORT Act”. (b)

42 USC 1862u note.

Findings.—The Congress finds that—(1) research gaps currently exist in the prevention and treatment of opioid addiction; (2) the National Science Foundation’s research on opioid addiction has increased understanding of the neuroscience of addiction, substance abuse intervention, the role of illicit supply networks, the secondary effects on families, the use of technology to address the opioid epidemic, and options for alternative, non-addictive therapeutics for pain; and (3) the National Science Foundation and the National Institutes of Health have recognized that fundamental questions in basic, clinical, and translational research would benefit greatly from multidisciplinary approaches and collaboration.
SEC. 2.

Consultation.

42 USC 1862u.

NSF SUPPORT OF RESEARCH ON OPIOID ADDICTION.  The Director of the National Science Foundation, in consultation with the Director of the National Institutes of Health, shall support merit-reviewed and competitively awarded research on the science of opioid addiction.
Approved January 13, 2021.
LEGISLATIVE HISTORY—H.R. 3153: HOUSE REPORTS: ┐No. 116–131 (Comm. on Science, Space, and Technology). SENATE REPORTS: ┐No. 116–248 (Comm. on Commerce, Science, and Transporta­tion). CONGRESSIONAL RECORD: Vol. 165 (2019):

July 23, considered and passed House.

Vol. 166 (2020):

Dec. 21, considered and passed Senate, amended.

Dec. 31, House concurred in Senate amendment.

 ○